Meristin

Quick links to important sections

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Meristin

Property Description
Active Ingredient Betahistine
Form Oral Tablet
Pharmacological Class Antivertigo Preparation
General Purpose Relieves symptoms of vertigo and dizziness
Origin Synthetic (Histamine Analogue)

What Type of Medicine is Meristin?

Meristin is a single-ingredient pharmaceutical preparation containing the active substance, Betahistine, and is formally categorized as an antivertigo preparation. This places it within the specialized pharmacological class designed to manage conditions that affect a patient’s sense of balance. The medication is typically supplied for systemic use in the solid dosage form of an oral tablet, intended for adult use and available by prescription.

Betahistine is a synthetic compound structurally identified as a histamine analogue, classified under the Anatomical Therapeutic Chemical (ATC) code N07CA01. Betahistine's structure relates to histamine, guiding its specific modulatory effects within the balance system.

Composition and General Purpose of Betahistine

The core of Meristin’s therapeutic action resides solely in the Betahistine component, which may be present as either the dihydrochloride or mesilate salt. Betahistine’s general function is to modulate the histaminergic system in a manner that supports the inner ear and central balance pathways.

The overarching general purpose of this therapy is to help alleviate the severe sensation of turning or spinning, known as vertigo, and other forms of associated dizziness that arise from dysfunction in the inner ear’s vestibular system. Betahistine is intended to address symptoms of vestibular vertigo. It plays a role in enhancing microcirculation and nerve signaling associated with equilibrium, helping the body to stabilize balance function.

What side effects are possible with Meristin?

Possible Side Effects and Safety Information

The safety profile for Meristin (Betahistine) is documented through clinical trial data and post-marketing surveillance, classified by regulatory authorities based on system-organ classes and frequency of occurrence.

Adverse reactions classified as Common (occurring in 1/100 to <1/10 of patients) primarily affect the nervous and gastrointestinal systems, including Headache, Nausea, and Dyspepsia (indigestion). Milder gastrointestinal complaints, such as Vomiting or Abdominal distension, have also been reported.

Less frequently, reactions linked to the Immune System and Skin have been reported through spontaneous post-marketing experience and are classified as Frequency Not Known. These include generalized Hypersensitivity reactions, such as Anaphylaxis, and serious cutaneous events like Angioneurotic oedema (localized swelling), Urticaria (hives), Rash, and Pruritus (itching).


Regulatory Safety Limitations

Official labeling defines specific safety constraints for Meristin. The medicine is Contraindicated in individuals with a rare adrenal gland tumor known as Phaeochromocytoma, due to the risk of severe hypertension.

Caution is advised for patients with a history of Peptic Ulcer or current ulceration, as well as those with Bronchial Asthma, Severe Hypotension, and certain allergic skin conditions (Urticaria, Rashes).

Population-specific notes state that use is not recommended for the Paediatric population (under 18 years) due to insufficient data. Similarly, due to limited information on potential risks, the medicine is advised against during Pregnancy and Lactation.

Overdose and Emergency Response

Overdose and when to seek help

The official regulatory documents define the overdose profile of Meristin (Betahistine) based on documented clinical experience, emphasizing both mild manifestations and the risk of severe complications associated with high-dose ingestion.

Overdose may be characterized by the manifestation of mild to moderate symptoms, including nausea, somnolence (drowsiness), and abdominal pain. Other officially reported signs may include vomiting, ataxia (impaired coordination), and dryness of the mouth. More serious or life-threatening outcomes, such as convulsions, seizures, and severe cardiac or pulmonary complications, are documented following the ingestion of very high doses, specifically in cases involving doses around 640 mg or higher, or when the substance is combined with other drugs.

In the event of a suspected overdose, regulatory authorities mandate that individuals must seek immediate medical attention. This action is required due to the documented risk of severe systemic complications. Contacting the local poison control center or immediately presenting to a hospital for severe symptoms is necessary regulatory guidance.

It is explicitly stated in official prescribing information that no specific antidote is known for Betahistine overdose. Therefore, management must consist only of symptomatic treatment and standard supportive measures. Procedural interventions like gastric lavage are officially recommended if performed within one hour of ingestion.

Therapeutic Uses of Meristin

What Meristin Treats: Main Uses and Benefits

Meristin (Betahistine) is a medicine generally used to help manage the symptoms associated with Ménière's disease and other peripheral vestibular disorders. These are conditions involving episodic or fluctuating manifestations that affect the inner ear's balance system. The medication is generally used to help with the acute or disruptive episodes of rotational vertigo (spinning), accompanying tinnitus (ringing), and feelings of aural fullness or pressure.

Meristin is used in cases where additional symptomatic support is needed. It is often used as a continuous, prophylactic therapy to address symptom clusters that may become intense or disruptive. The therapy contributes to easing the overall symptom load during symptomatic phases, providing supportive relief when symptoms interfere with routine activities, and may assist with maintaining functional stability during symptomatic phases.

“The therapy contributes to easing the overall symptom load during symptomatic phases, providing supportive relief when symptoms interfere with routine activities.”


Quick Fact: Relief for Rotational Vertigo


Eligibility and Restrictions for Use

Meristin, a combined oral contraceptive (COC) containing both estrogen and progestin, is suitable for use by most healthy women of reproductive age. However, due to the estrogen component, it is contraindicated for individuals with certain medical conditions that increase the risk of serious side effects, such as blood clots.

Contraindications

Individuals who must not use Meristin include those with the following absolute contraindications:

  • A history of or current venous thromboembolism (VTE), such as deep vein thrombosis (DVT) or pulmonary embolism (PE).
  • Ischemic heart disease or a history of stroke.
  • Severe uncontrolled hypertension (high blood pressure) or hypertension with vascular disease.
  • Migraine headaches with focal neurological symptoms (aura), regardless of age.
  • Current or past breast cancer.
  • Liver tumors (adenoma or carcinoma) or severe, decompensated cirrhosis.
  • Known thrombogenic mutations (e.g., Factor V Leiden).
  • Women over age 35 who smoke 15 or more cigarettes per day.
  • Women who are less than 21 days postpartum.

Precautions and Relative Contraindications

Certain conditions, such as controlled hypertension, age over 35 (even with light smoking), or mild liver impairment, require careful consideration, and a healthcare provider must weigh the benefits against the risks. Meristin is generally not recommended for use in children or adolescents who haven't started menstruating.

What should I know about interactions with other medicines?

Interactions with other medicines and products

The official regulatory profile for Meristin (Betahistine) documents interactions primarily based on metabolic pathways and pharmacodynamic effects, with no combinations formally classified as contraindicated due to interaction risk.

Interaction Scope

Property Value
Medicinal product categories with documented interactions Monoamino-oxidase Inhibitors (MAOIs); Antihistamines; Herbal Remedies and Supplements.
Specific interacting medicines (if explicitly listed) Selegiline (as an example of an MAO-B inhibitor).
Mechanistic basis of interactions Inhibition of Betahistine metabolism by MAOIs (Pharmacokinetic); Theoretical antagonism with Antihistamines (Pharmacodynamic).
Timing-based interaction rules None documented.

Official Interaction Statements

Co-administration with Monoamino-oxidase Inhibitors (MAOIs), including selective MAO-B inhibitors such as Selegiline, is documented to inhibit the metabolism of Betahistine. This effect is expected to result in increased plasma exposure and reduced clearance of Betahistine. Caution is officially recommended when these substances are used concomitantly.

Antihistamines ( H1-receptor antagonists) are documented to have a theoretical pharmacodynamic antagonism with Betahistine, which may affect the efficacy of one or both substances. Furthermore, regulatory sources note there is insufficient safety information regarding co-administration with herbal remedies and supplements.

Mechanism of Action

Meristin (Betahistine) is a pharmacodynamic agent with a dual mechanism of action centered on the histaminergic system to modulate activity within the central and peripheral equilibrium pathways. The overall effect is achieved through the complementary actions of central modulation and peripheral vascular influence.


Modulating Central Balance Processing via the H3-Receptor

The primary mechanism involves acting as an antagonist at the histamine H3-receptors (H3) located in the brain, particularly within the vestibular nuclei . This action removes an inhibitory feedback loop, which leads to an increased release and turnover of natural histamine and other associated neurotransmitters in the CNS. The resulting increase in neurotransmitter availability modulates the central neuronal response to facilitate the vestibular compensation process. This action adjusts the processing of signals originating from the inner ear.


Influencing Inner Ear Perfusion through the H1-Receptor

A secondary, weak agonistic action is observed at the histamine H1-receptors (H1) on local blood vessels, particularly those supplying the inner ear's sensory structures. This effect promotes localized vasodilation, increasing blood flow and perfusion to the labyrinth and cochlea. This physiological change alters the perfusion status of the neuroepithelium and influences the local fluid dynamics within the balance organs.

Dosage and Administration Information

How to Use Meristin

Meristin is an oral tablet for systemic use, administered strictly through the oral route. The general principle of administration involves dividing the total daily amount into separate doses to maintain consistent levels of the active substance, Betahistine.

Standard Administration Protocol

The total daily dosage is typically flexible, ranging from 24 mg to 48 mg in adults. This total amount is customarily split and taken in two or three separate doses throughout the day.

  • Dosing Ceiling: The dose is adjusted by a healthcare provider, but should not exceed the official maximum daily dose of 48 mg.
  • Timing: The tablets are generally instructed to be taken with or immediately after meals. This principle of use is designed to mitigate potential gastrointestinal discomfort.
  • Duration: Treatment with Meristin is typically long-term. Therapeutic benefits often require several weeks of continuous, consistent use to fully manifest, with optimal effects sometimes requiring a few months.

Handling and Use in Specific Groups

The tablets should be swallowed whole, though scored strengths (e.g., 16 mg and 24 mg) may be divided to aid swallowing or allow for precise dose adjustment. If a dose is missed, it is generally recommended not to double the subsequent dose; the patient should simply wait and take the next dose at the regularly scheduled time.

For older adults, a routine dose adjustment is not typically required. However, the use of Meristin is not recommended for children and adolescents under 18 years of age due to insufficient data regarding its safety and efficacy in this population.

Recent Clinical Evidence

The research for Meristin (Betahistine) has focused on its two main contexts: managing Ménière's disease and addressing symptoms of peripheral vestibular vertigo. This overview describes what the studies examined and what remains uncertain about the evidence.


Evidence for use in Ménière's Disease

The research primarily relies on Randomized Controlled Trials (RCTs) and systematic reviews that examined outcomes related to episodic changes, including the frequency, intensity, and duration of vertigo attacks. Research also examined patient-reported experiences of associated symptoms like tinnitus and aural fullness. Evidence is limited and findings have been mixed across different trials. Certainty remains low because the majority of studies identified by reviewers had methodological limitations and sample sizes were modest, making it difficult to draw firm conclusions about long-term symptom patterns.


Evidence for use in Peripheral Vestibular Vertigo

Research for general peripheral vestibular vertigo was evaluated in RCTs and large-scale Post-marketing Observational Studies. The research examined patient-reported outcomes describing perceived discomfort and functional measures, such as the Dizziness Handicap Index (DHI). While observational data contributes to understanding symptom patterns in daily life, comparative evidence is lacking in key areas. The overall evidence level for this broader application is generally characterized as moderate.


Research Gaps and Uncertainty

The research landscape highlights several key uncertainties. Long-term effects are not fully established because follow-up durations were limited in many core trials. Furthermore, data for children and adolescents are generally insufficient. The primary research gap is the continuing need for large-scale, high-quality, double-blind RCTs that can contribute to the broader evidence landscape.

Key Studies & References Meta-analysis of clinical studies with betahistine in Meniere's disease and vestibular vertigo

Frequently Asked Questions (FAQ)

Common questions about Meristin (FAQ)

Q: Are there any common over-the-counter medications that interact with Meristin?

Official product information states that the medicine may interact with certain drugs, specifically MAO inhibitors (used to treat depression or Parkinson's disease) and Antihistamines (often found in allergy or cold medicines). Because the theoretical effects of Antihistamines may counter the action of Meristin, information about concurrent use should be shared with the prescribing professional. Furthermore, official documents note there is insufficient safety data for co-administration with herbal remedies and supplements.

Q: Is there a maximum time a person should be on Meristin?

According to regulatory documents, treatment with Meristin is typically considered long-term, as it may take several months of consistent use to achieve the best results. Official product information does not specify an absolute maximum time limit for using the medication. The duration of treatment is determined under the guidance of a healthcare professional.

Q: Why do official sources mention certain foods or drinks to avoid with Meristin?

Official product information recommends taking the Meristin tablets with or immediately after meals. This administration advice is in place to help prevent or reduce the possibility of mild gastrointestinal side effects, such as nausea or stomach upset, which are commonly reported. The food itself is not an interaction concern but a way to manage digestive comfort.

Q: Can Meristin cause unusual tiredness or sleepiness?

Official safety documentation indicates that drowsiness or unusual sleepiness has been reported, although this is classified as an uncommon or rare side effect. If an excessive amount of the medicine is taken (overdose), symptoms may include somnolence. Drowsiness is a side effect that may impair a person’s ability to drive or operate machinery.

Q: Is Meristin available without a prescription in some countries?

Meristin is a drug that requires a prescription from a licensed healthcare provider in most countries where it is formally approved and marketed, such as across Europe and Canada. Official regulatory bodies classify the medicine as a prescription-only substance (℞).

Q: Does Meristin require any special lab tests while I am using it?

The official Product Monograph for Meristin includes a section dedicated to Monitoring and Laboratory Tests. This indicates that the Product Monograph addresses the topic of Monitoring and Laboratory Tests, which may be part of the individual's care plan.

Q: What is the risk of dependence or addiction with Meristin?

Official patient information from regulatory sources states that there is no evidence to suggest that taking Meristin carries a risk of dependence or is considered an addictive substance. The drug is not classified as a controlled substance in the jurisdictions where it is approved.

Q: Is it true that Meristin has a 'black box warning'?

No, the official regulatory labeling for Meristin (Betahistine) in the jurisdictions where it is approved does not include a 'black box warning,' which is the strongest type of warning required by some regulatory bodies like the FDA.

Q: How quickly does Meristin leave the body after stopping its use?

The active ingredient in Meristin is quickly absorbed by the body. According to pharmacokinetic studies, the majority of the drug and its primary breakdown product (metabolite) are naturally eliminated, with approximately 85–91% excreted in the urine within 24 hours after the dose is taken.

Q: Can Meristin affect mood or cause emotional changes?

Official safety data and regulatory documents do not list mood changes, anxiety, or specific emotional changes among the common or known side effects of Meristin. Side effects reported are usually related to the nervous system (like headaches) or the digestive system.

Q: Is Meristin safe for people with existing liver conditions?

While there is limited data from clinical trials specifically focused on patients with existing liver impairment (hepatic impairment), post-marketing experience suggests that a dose adjustment is typically not necessary. Use in patients with hepatic impairment is managed under the supervision of a healthcare professional.

Q: Can people with kidney problems use Meristin?

Regulatory data indicates that there is no specific dose adjustment considered necessary for patients with existing kidney impairment (renal impairment), based on post-marketing reports. Use in patients with renal impairment is managed under the supervision of a healthcare professional, based on the patient's individual condition.

Q: Does Meristin interact with alcohol?

Official patient safety information advises caution regarding the consumption of alcohol while using this medicine. Alcohol intake may potentially increase or worsen certain side effects, such as dizziness or tiredness, or may exacerbate the symptoms of the underlying condition Meristin is treating.

Q: Can Meristin be used for conditions other than its main approved use?

Regulatory guidance states that Meristin should only be used to treat the specific conditions that it has been approved for, as detailed in the official product labeling. Official labeling specifies that the medicine is only indicated for its approved uses.

Q: Can Meristin cause weight changes?

Official safety documents, which list common and known side effects from clinical trials and post-marketing experience, do not include weight gain or weight loss among the frequently reported adverse events for Meristin.

Q: What should I do if I think I am having a side effect from Meristin?

If a patient suspects a side effect while taking this medicine, suspected side effects are typically reported to the healthcare provider for evaluation. Official guidance also allows patients to report any suspected or actual side effects directly to the national regulatory body that oversees drug safety in their region.

Q: Is there a generic version of Meristin available?

Yes, the active substance in Meristin, which is Betahistine, is available globally under various brand names, and also as a certified generic equivalent in many markets. Generic versions contain the identical active ingredient in the same strength as the brand-name product.

Q: Does Meristin affect fertility?

According to regulatory reviews and official safety information, there is currently no evidence to suggest that using Meristin has a negative effect on fertility in either men or women.

Q: What is the difference between the brand name Meristin and its generic equivalent?

Brand-name Meristin and its generic equivalents both contain the identical active ingredient (Betahistine) in the same strength and dosage form. The primary differences lie in the inactive ingredients (like fillers or coloring), the brand name, and typically the cost. Both must meet the same quality standards set by regulatory authorities.

Q: Is Meristin a controlled substance?

No, Meristin (Betahistine) is officially classified as a non-controlled, prescription-only medication in the regulatory jurisdictions where it is marketed. It is not subject to the special legal restrictions associated with controlled substances.

How should Meristin be stored and disposed of?

How to Store and Dispose of Meristin

Storing Meristin (Betahistine) tablets requires adherence to specific conditions to maintain stability. The medicine must be stored at a temperature not exceeding 30 C; some regional standards specify a maximum of 25 C. It is mandatory to protect the tablets from moisture by keeping the container tightly closed and storing the product in a dry place. The medication should be kept in its original package. For safety, all medicines must be kept out of reach of children.

Disposal of unused or expired Meristin should follow local regulations for pharmaceutical waste. Unless otherwise instructed on the label, no special hazardous waste handling is required for the oral tablets.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Meristin found in:

A-Z Index: